Drug factory · FDA FEI 3008477458
Laboratorio Italiano Biochimico Farmaceutico Lisapharma SPA
Via Licinio 11, Erba, Italy
Problems found, fixed voluntarily at FDA's last inspection, Jan 26, 2024.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
2 drug inspections on record since 2023: 0 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Methylprednisolone | Makes it | Sandoz Inc. | 0781-3516, 0781-3522 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jan 26, 2024 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Sep 26, 2023 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: manufacture.